Of note, in a mouse model of colorectal cancer, disruption of NETs with DNAse I improves survival and leads to diminished tumor volume via enhanced CD8+ T-cell cytotoxicity, especially when combined with anti-PD-1 therapy [14]. The gene discussed is CD8A; the disease is neoplasm.